AstraZeneca to pay $30M upfront to license rare heart condition drug from Neurimmune
01 März 2022 - 10:35AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
AstraZeneca (NYSE:AZN)
Historical Stock Chart
Von Jun 2022 bis Jul 2022
AstraZeneca (NYSE:AZN)
Historical Stock Chart
Von Jul 2021 bis Jul 2022